Hospital News and Research

RSS

Simple soft-drink cooler could help patients battle antibiotic-resistant TB

Tuberculosis, now largely controlled in the industrialized world, remains a stubbornly persistent killer in most of Africa, as well as parts of Asia and South America. The spread of multidrug-resistant strains of TB has slowed progress against the devastating disease, which is estimated to strike more than 10 million people annually. Now a modified soft-drink cooler, developed by researchers at MIT's D-Lab, could make a dent in the disease's impact.

31 May 2012

YCC, SCRI and SCH partner to advance cancer research

Sarah Cannon Research Institute (SCRI) today announced the finalization of an agreement to collaborate scientifically with Yale Cancer Center (YCC) and Smilow Cancer Hospital at Yale-New Haven (SCH) to advance cancer research.

31 May 2012

RUSM, KMC announce 10-year affiliation agreement

Ross University School of Medicine (RUSM) and Kern Medical Center (KMC) in Bakersfield, Calif. today announced a 10-year affiliation agreement to allocate, on an annual basis, a significant number of core clinical rotation slots to RUSM students.

31 May 2012

Clorox Healthcare to be showcased at APIC 2012 conference

Clorox Professional Products Company, a division of The Clorox Company, will showcase Clorox Healthcare, its new strengthened comprehensive product offerings and educational initiatives to meet healthcare professionals' diverse needs, at the Association for Professionals in Infection Control and Epidemiology (APIC) 2012 Conference in San Antonio, Texas, June 4-6.

31 May 2012

Study examines how SMIP-016 drug kills CLL cells

A new study has identified a life-and-death signaling role for a molecule on the surface of the immune cells involved in the most common form of chronic leukemia. The finding could lead to more effective therapy for chronic lymphocytic leukemia (CLL), an as yet incurable cancer that occurs in more than 16,000 Americans annually.

31 May 2012

CTI announces results from PIX301 phase 3 trial of Pixuvri for NHL

Cell Therapeutics, Inc. today announced that results from its PIX301 phase 3 clinical trial of Pixuvri (pixantrone) have been published online in The Lancet Oncology.

31 May 2012

Most immigrant pregnant women in Spain suffer severe stress

A study conducted at the University of Granada has concluded that most immigrant women who give birth in Spain suffer "severe stress" and should receive psychological treatment after giving birth to help them overcome disorders such as obsessive compulsive disorder, phobic anxiety, depression or psychoticism. These disorders are caused by "the stress of labor itself combined with other personal stress factors. This is a very stressful moment in women's life due to biological, psychological and social factors".

31 May 2012

State roundup: Minn. defends Medicaid billing; Cigna, N.H. Group form joint venture; Health coupons in Mass.

Top Minnesota health officials pushed back Tuesday against a congressional committee probing allegations that the state overbilled federal taxpayers for Medicaid services to cover losses from in other state-run public health programs. In a letter to the House Oversight and Government Reform Committee, Minnesota Human Services Commissioner Lucinda Jesson defended reforms implemented under DFL Gov. Mark Dayton, saying "our focus has been on changing course rather than investigating the past."

31 May 2012

Top-line results from Alnylam’s ALN-RSV01 Phase IIb trial on RSV infection

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today top-line results from a Phase IIb trial with ALN-RSV01 for the treatment of respiratory syncytial virus (RSV) infection in lung transplant patients.

31 May 2012

Texas hospital selects Spacelabs for patient monitoring and connectivity solutions

OSI Systems, Inc., a vertically integrated provider of specialized electronic products for critical applications in the security and healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received an approximate $4 million contract to provide its state-of-the-art solutions to a Texas hospital's new Telemetry, Intensive Care and Emergency Departments.

31 May 2012

Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC

Exelixis, Inc. today announced the initiation of COMET-1, a phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer.

31 May 2012

AssureRx closes $12.5M Series C financing

AssureRx Health, Inc. today announced the closing of a $12.5 million Series C financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients, will use the funds to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx Psychotropic and GeneSightRx® ADHD, as well as next generation product development activities.

31 May 2012

In new models for care, seniors look at co-housing options while patients elsewhere get hospital care at home

Some elderly residents of North Carolina are exploring co-housing options to avoid having to leave their homes. Meanwhile, in a few spots health leaders are instituting the "hospital at home" concept.

31 May 2012

Insulin use linked to lung cancer risk in diabetes

Postmenopausal women with treated diabetes may be at an increased risk for lung cancer, particularly if they are on insulin, say researchers.

30 May 2012

Bedside tool improves prognostication after cardiac arrest

A bedside prediction tool could estimate the probability of favorable neurologic survival in successfully resuscitated patients after in-hospital cardiac arrest, say researchers in the Archives of Internal Medicine.

30 May 2012

Anxiety increases symptom severity in acute mania patients

Anxiety is common in patients experiencing an episode of acute mania and is associated with more severe mood symptoms, researchers report.

30 May 2012

New technique promotes dramatic increase in cardiac function

LoneStar Heart Inc., today announced the advancement of a new therapeutic strategy aimed at genetic reprogramming of cardiac fibroblasts into functioning heart muscle cells to treat damage following a heart attack and other forms of heart disease.

30 May 2012

Law aims to illuminate financial links between doctors and pharmaceutical companies

A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.

30 May 2012

Insurers make patients pay hundreds more for cancer, arthritis drugs

Thousands of patients taking costly drugs for ailments such as cancer and rheumatoid arthritis are being asked to shoulder a greater share of the expense. In other news, consumers are demanding access to their medical device data. Others are harnessing the internet to jumpstart medical research and share important experiences, including serious illnesses, with family and friends.

30 May 2012

Study reveals new evidence of trans-cranial bright light's effect to brain functions

A recent placebo-controlled study reveals new evidence of trans-cranial bright light's effect to brain functions when administered through the ear. Bright light stimulation was found to increase activity in brain areas related to processing of visual sensory information and tactile stimuli. The findings constitute the first ever published scientific article about functional modulation of the brain with bright light delivered to the brain through the ears. The study was published today May 29th, 2012 in the World Journal of Neuroscience.

30 May 2012